ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ENDP Endo International PLC

0.2926
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Endo International PLC NASDAQ:ENDP NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.2926 0.29 0.294 0 01:00:00

Endo to Announce Third-Quarter 2017 Financial Results

09/10/2017 12:30pm

PR Newswire (Canada)


Endo (NASDAQ:ENDP)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Endo Charts.

DUBLIN, Oct. 9, 2017 /CNW/ -- Endo International plc (NASDAQ: ENDP) will announce its third-quarter 2017 financial results on November 9, 2017 and members of its senior management team will host a conference call and webcast after the U.S. financial markets close at 4:30 p.m. ET.

The dial-in number to access the call is U.S./Canada (866) 497-0462, International (678) 509-7598, and the passcode is 92375212. Please dial in 10 minutes prior to the scheduled start time.

A replay of the call will be available from November 9, 2017 at 7:30 p.m. ET until 7:30 p.m. ET on November 23, 2017 by dialing U.S./Canada (855) 859-2056, International (404) 537-3406, and entering the passcode 92375212.

A simultaneous webcast of the call can be accessed by visiting www.endo.com. In addition, a replay of the webcast will be available until 7:30 p.m. ET on November 23, 2017. The replay can be accessed by clicking the Investor Relations section of the website.

About Endo International plc

Endo International plc (NASDAQ: ENDP) is a highly focused generics and specialty branded pharmaceutical company delivering quality medicines to patients in need through excellence in development, manufacturing and commercialization. Endo has global headquarters in Dublin, Ireland, and U.S. headquarters in Malvern, PA. Learn more at www.endo.com.

View original content:http://www.prnewswire.com/news-releases/endo-to-announce-third-quarter-2017-financial-results-300532858.html

SOURCE Endo International plc

Copyright 2017 Canada NewsWire

1 Year Endo Chart

1 Year Endo Chart

1 Month Endo Chart

1 Month Endo Chart

Your Recent History

Delayed Upgrade Clock